A comprehensive view of Phase 2 Trial. This page highlights a small sample of our full coverage.
For real-time access, please log in to your R&D/Patents Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Plus Therapeutics partners with Biocept to use Biocept’s CNSide cerebrospinal fluid assay in ReSPECT-LM Phase 1/2a clinical trial of injectable Rhenium-186 nanoLiposome to treat leptomeningeal metastases, a cancer of brain, spinal cord membranes

Merck reports experimental injectable pneumococcal vaccine V116 met primary immunogenicity objectives in Phase 1-2 study; vaccine targets 21 strains of Streptococcus pneumoniae that cause 85% of pneumonia cases in adults 65 years and over in US

GSK Immunotherapy Shows Promise As Alternative To Surgery In Certain Rectal Cancers

Aim Immunotech prepares application for Phase 2 trial in US of Ampligen rintatolimod injectable to treat post-COVID conditions; drug is approved in Argentina to treat myalgic encephalomyelitis, or chronic fatigue syndrome

Janssen reports Phase 2 GALAXI 1 clinical trial shows efficacy, safety of Tremfya guselkumab, Stelara ustekinumab to treat inflammatory bowel disease; in US, Crohn’s Disease affects 3 million people, ulcerative colitis affects about 1 million people

Ask us about our R&D/Patents market view

Trending Chart

Interactive chart with headline count